Sarepta (SRPT) PT Raised to $76 at Oppenheimer Amid Eteplirsen Approval

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. PANW
2. GTLB
3. MDB
4. DELL
5. SPY
6. MMED
7. CRDO
8. AAPL
9. GFS
10. NVDA

Go back to Sarepta (SRPT) PT Raised to $76 at Oppenheimer Amid Eteplirsen Approval
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 21.76 +0.43 (2.02%)
Previous Close $21.33    52 Week High $63.73 
Open $21.33    52 Week Low $8.00 
Day High $22.45    P/E N/A 
Day Low $21.33    EPS $-5.69 
Volume 166,666